Although tuberculosis (TB) is both preventable and curable, it remains one of the world's deadliest infectious diseases. Beyond its physical impact, TB continues to affect millions of people through stigma, social exclusion, and barriers to healthcare. In countries such as Indonesia, where the burden of TB remains particularly high, addressing these challenges requires not only medical solutions but also greater awareness, community engagement and international collaboration.
According to the World Health Organization (WHO), an estimated 10.6 million people developed TB globally in 2025. Indonesia accounted for approximately 10% of these cases, making it the country with the second-largest share of the global TB incidence (World Health Organization, 2026). WHO reported that approximately 134,000 people die from tuberculosis each year in Indonesia, highlighting the continued need for effective prevention, early diagnosis and access to treatment (Anandita & Christian, 2026).
As part of AJ Vaccines' Voices in the Fight Against TB series, we spoke with Ani Herna Sari at the 2025 Union World Conference on Lung Health in Copenhagen. A two-time TB survivor, advocate, co-chair of the Global tuberculosis Community Board (TB CAB) and chairperson of the non-profit organization Rekat Peduli Indonesia, Ani has dedicated herself to supporting people affected by tuberculosis and raising awareness within communities.
Having experienced TB and drug-resistance against TB during her first pregnancy, Ani understands how the disease can affect far more than physical health. Today, she uses her experience to support people affected by TB, encouraging them to seek care, complete treatment, and recognize that a diagnosis does not define their future.
As she explained in her interview with AJ Vaccines: "We make them realise that TB is preventable and curable."
Her message reflects an important aspect of the global TB response: people affected by tuberculosis need not only access to healthcare, but also understanding, respect and support throughout their treatment journey.
Despite continued progress in TB prevention and treatment, stigma remains a barrier for many individuals and communities. Fear of being judged, excluded, lose income or misunderstood can discourage people from seeking medical advice or speaking openly about their symptoms. Economic difficulties, geographical distances, and limited access to healthcare services can create additional obstacles.
Through her work with the non-profit organization, founded in 2014, Rekat Peduli Indonesia, Ani helps address these challenges by engaging with communities, sharing knowledge on tuberculosis disease and drug resistance as well as supporting people throughout their treatment.
Speaking about the importance of looking beyond medical treatment, Ani emphasized: "It's about dignity, equity, and ensuring that no one is left behind."
Her perspective highlights that raising awareness is not simply about increasing knowledge of an infectious disease; it is also about creating environments in which people feel supported, understood and empowered to seek the care they need.
Strengthening awareness, reducing stigma, and improving access to specialized healthcare centers all play an important role in supporting the global efforts to end tuberculosis.
As part of the ongoing commitment to the fight against TB, AJ Vaccines is participating in the Union World Conference on Lung Health 2026 in Rio de Janeiro. The conference will bring together experts, advocates, policymakers, and organizations from around the world to exchange knowledge, share experiences, and discuss strategies for accelerating progress against tuberculosis. AJ Vaccines will participate in the conference as an opportunity to strengthen relationships, exchange perspectives and engage with stakeholders working to improve the global TB response.
Ending TB requires more than a single solution. It requires sustained attention, meaningful partnerships, and a shared commitment to ensuring that tuberculosis, and the people affected by it, are not forgotten.
Read the full interview with Ani here: Ani Herna Sari on dignity in Tuberculosis care | AJ Vaccines